Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-05-28

FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ranitidine from Pharmaceutical Associates, Inc., indicating a labeling or related change to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranitidine (Ranitidine)

Snippet

SUPPL AP for RANITIDINE (RANITIDINE)